Prosecution Insights
Last updated: April 19, 2026

Myokardia Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18390537 Methods of Administering Myosin Inhibitors BORI, IBRAHIM D 1629 Final Rejection Dec 20, 2023
18227402 CRYSTALLINE FORMS OF (6S,7S)-6-FLUORO-7-(2-FLUORO-5-METHYLPHENYL)-3-(TETRAHYDRO-2H-PYRAN-4-YL)-5,6,7,8-TETRAHYDROPYRIDO[2,3-d]PYRIMIDINE-2,4(1H,3H)-DIONE DROUIN, STEVE HOANG 1627 Non-Final OA Jul 28, 2023
18001896 TREATMENT OF ATRIAL DYSFUNCTION NGUYEN, JOHN P 1619 Non-Final OA Dec 15, 2022

Managing Myokardia Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month